Hologic earnings beat by $0.04, revenue topped estimates

Investing.com – Hologic (NASDAQ: ) reported third quarter EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $984.4M versus the consensus estimate of $959.92M.

Guidance

Hologic sees Q4 2023 EPS of $0.80-$0.87 versus the analyst consensus of $0.87.

Hologic sees Q4 2023 revenue of $910.00M-$950.00M versus the analyst consensus of $950.00M.

Hologic sees FY 2023 EPS of $3.87-$3.94 versus the analyst consensus of $3.88.

Hologic sees FY 2023 revenue of $4.00B-$4.04B versus the analyst consensus of $4.02B.

Hologic’s stock price closed at $79.42. It is down -3.67% in the last 3 months and up 11.94% in the last 12 months.

Hologic saw 9 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Hologic’s stock price’s past reactions to earnings here.

According to InvestingPro, Hologic’s Financial Health score is “great performance”.

Check out Hologic’s , and Hologic’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar